Senators questioned Mehmet Oz, MD, MBA, on Medicaid budget cuts, nursing shortages and his prior claims about miracle drugs during a committee hearing to be the next administrator of CMS ...

The fund owned 6,035 shares of the medical instruments supplier’s stock after purchasing an additional 502 shares during ... and sells insulin delivery systems for people with insulin-dependent ...

The agency will reject all data from the Chinese service provider’s studies after Mid-Link failed to address concerns outlined in a warning letter last year, FDA officials said.